Dilutional rheology of Radiesse: implications for regeneration and vascular safety
An FDA-approved medication (brand name Vyleesi ) indicated for premenopausal women with hypoactive sexual desire disorder, PT-141 stimulates melanocortin receptors in the brain to enhance arousal and desire in both sexes
Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
The Precision Peptide Genetic Test does not predict response to liraglutide or any drug
Importance of Open Discussions Open discussions of fears and concerns are critical to quality care
The subsequent phase 3 trial of tirzepatide demonstrated more effective reductions in the glycated hemoglobin levels and body weight, along with greater overall improvements in the lipid profile compared to semaglutide in patients with T2DM, elevating incretin therapeutic agents to a new level (112)